DistantNews
Support us
Norway to use anonymized health data for AI model development
๐Ÿ‡ณ๐Ÿ‡ด Norway /Health & Science

Norway to use anonymized health data for AI model development

From Aftenposten · () Norwegian

Translated from Norwegian, summarized and contextualized by DistantNews.

At a glance

News Official statement New plan
  • Norway plans to use sensitive health data for developing AI models, anonymizing personal information.
  • The digitalization minister intends to share these anonymized datasets with pharmaceutical and technology companies.
  • The initiative aims to advance medical research and treatment methods through AI.

Norway is moving forward with a plan to leverage sensitive health data for the development of artificial intelligence models. Digitalization Minister Karianne Tung announced that personal information will be translated into anonymized datasets, ensuring privacy while enabling technological advancement.

These anonymized datasets are intended to be shared with pharmaceutical industries and technology companies. The goal is to accelerate progress in areas such as medical research, treatment methods, and the development of new healthcare technologies, particularly through the application of AI.

The initiative acknowledges the highly private and sensitive nature of health information, including diagnoses and test results. By transforming this data into a format that removes personal identifiers, Norway aims to strike a balance between protecting individual privacy and harnessing the potential of health data for broader societal benefit.

While the article does not detail specific AI models or research projects, it signals a strategic direction for Norway in utilizing its health data resources. The move is positioned as a way to keep pace with the rapid advancements in digital health and AI-driven innovation globally.

DistantNews Editorial

Originally published by Aftenposten in Norwegian. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.